Pediatrics · Rexburg, ID
NPI
1265637573
Since 2007
Specialty
Pediatrics
Code 208000000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
380 Walker Dr
Rexburg, ID, 83440
Phone (208) 356-9559
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
330 services
Medicare patients, 2024
168
Average age 72
Drug cost, 2024
$2.0M
694 prescriptions
Company payments, 2025
$3,087
From 44 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey D Hancock was code 99215 (office e&m - established), 270 times for 134 patients. In total Jeffrey D Hancock billed 330 services in 9 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 270 | 134 | $98.03 | $26K |
| 99205 Office E&M - New | Office | 40 | 40 | $128.67 | $5,147 |
By year: 2022 $45K for 442 services; 2023 $37K for 363 services; 2024 $32K for 330 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey D Hancock prescribed most often to Medicare patients was Eliquis (Apixaban), with 53 prescriptions and refills. In total Jeffrey D Hancock wrote 694 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 53 | 71 | Under 11 | $43K |
| Lenalidomide Generic | 46 | 46 | Under 11 | $719K |
| Hydroxyurea Generic | 37 | 74 | Under 11 | $1,100 |
| Xarelto Rivaroxaban | 31 | 43 | Under 11 | $23K |
| Anastrozole Generic | 29 | 55 | Under 11 | $495 |
| Levothyroxine Sodium Generic | 29 | 71 | Under 11 | $404 |
| Tamoxifen Citrate Generic | 25 | 71 | Under 11 | $915 |
| Koselugo Selumetinib Sulfate | 24 | 24 | Under 11 | $302K |
| Ondansetron Odt Ondansetron | 21 | 21 | Under 11 | $241 |
| Lorazepam Generic | 15 | 17 | Under 11 | $102 |
| Prednisone Generic | 15 | 27 | Under 11 | $205 |
| Dexamethasone Generic | 15 | 21 | Under 11 | $418 |
| Levofloxacin Generic | 14 | 14 | Under 11 | $58.81 |
| Imbruvica Ibrutinib | 14 | 14 | Under 11 | $228K |
| Famotidine Famotidine/Pf | 13 | 13 | Under 11 | $34.06 |
Brand drugs: 197 claims; generic drugs: 497 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey D Hancock $3,087 ($3,087 in general payments such as food, travel and fees) from 44 companies. The largest payer was Jazz Pharmaceuticals Inc. with $283.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 11 | $283 |
| Merck Sharp & Dohme LLC MRK | 10 | $209 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $199 |
| Janssen Biotech, Inc. JNJ | 9 | $198 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $161 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $156 |
| Daiichi Sankyo Inc. 4568.T | 5 | $129 |
| BeOne Medicines USA, Inc. ONC | 4 | $123 |
| Abbvie Inc. ABBV | 6 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $112 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.